Beijing Sanbo Brain Hospital
Beijing Sanbo Brain Hospital
Explore linked clinical trials.16 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Spinal Cord Stimulation for Poststroke Spasticity | Muscle Hypertonia, Muscle Spasticity, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Not applicable | 2026-09-21 | NCT07744659 | |
| The Efficacy and Safety of Pregabalin Combined With Venlafaxine in Patients With Fibromyalgia | Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, fibromyalgia, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, neuromuscular disease, rheumatic disorder | Recruiting | Not applicable | 2026-09-02 | NCT07186751 | |
| Multi-Parameter Temporal Interference Stimulation in Patients With Epilepsy Undergoing SEEG Monitoring | brain disorder, central nervous system disorder, epilepsy, nervous system disorder | Not yet recruiting | Not applicable | 2026-08-27 | NCT07790224 | |
| Dexamethasone Palmitate for Postoperative Pain | Neurologic Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Postoperative Pain, Signs and Symptoms | Recruiting | Not applicable | 2026-08-19 | NCT07341854 | |
| Efficacy and Safety of Oral Antiviral Therapy for Idiopathic Trigeminal Neuralgia | Stomatognathic Diseases, Trigeminal Neuralgia, Idiopathic, cranial nerve neuropathy, facial nerve disorder, facial neuralgia, mouth disorder, nervous system disorder, trigeminal nerve disorder, trigeminal neuralgia | Not yet recruiting | Not applicable | 2026-06-29 | NCT07673549 | |
| The Efficacy and Safety of Short Term S-ketamine Infusion as an Adjunctive Therapy in Patients With Fibromyalgia | fibromyalgia, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, neuromuscular disease, rheumatic disorder | Recruiting | Not applicable | 2026-05-07 | NCT07230171 | |
| Subthalamic Nucleus Electrical Stimulation for Drug-resistant Focal Motor Epilepsy | Drug Resistant Epilepsy, brain disorder, central nervous system disorder, epilepsy, focal epilepsy, nervous system disorder, partial motor epilepsy | Recruiting | Not applicable | 2025-07-15 | NCT06248333 | |
| Electroencephalogram Predicts Post-operative Delirium | Confusion, Emergence Delirium, Neurobehavioral Manifestations, Neurologic Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Signs and Symptoms, cognitive disorder, delirium, nervous system disorder, psychiatric disorder | Recruiting | Not stated | 2025-03-25 | NCT06894238 | |
| Vebreltinib Combined With Temozolomide for Glioblastoma (GBM) After Surgery | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Not yet recruiting | Phase 2 | 2025-01-22 | NCT06780592 | |
| The Effectiveness and Safety of Resective Epilepsy Surgery for TRE | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Malformations of Cortical Development, Group I, Neoplasms, Multiple Primary, brain disorder, central nervous system disorder, central nervous system malformation, cerebral cortical dysplasia, epilepsy, hamartoma, hereditary disease, hereditary neoplastic syndrome, inherited neurodegenerative disorder, neoplasm, nervous system disorder, neurocutaneous syndrome, neurodegenerative disease, tuberous sclerosis | Active, not recruiting | Not stated | 2025-01-17 | NCT04198181 | |
| Retrospective Study of Germ Cell Tumors of the Central Nervous System | central nervous system germ cell tumor | Active, not recruiting | Not stated | 2024-10-15 | NCT05836701 | |
| Modified CV Regimen in Optic Pathway Glioma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, cranial nerve neoplasm, cranial nerve neuropathy, epithelial neoplasm, eye disorder, glioma, neoplasm, nervous system disorder, neuroepithelial neoplasm, optic nerve disorder, optic nerve glioma, optic nerve neoplasm, peripheral nervous system neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 2 | 2024-10-15 | NCT05278715 | |
| Apatinib Combined with Temozolomide and Etoposide Capsules in the Treatment of Recurrent Medulloblastoma in Children | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, epithelial neoplasm, glioma, medulloblastoma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 2 | 2024-10-15 | NCT04501718 | |
| Apatinib in the Treatment of Recurrent Atypical/malignant Meningioma in Adults | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Nerve Tissue, central nervous system cancer, meningioma, neoplasm, nervous system disorder, tumor of meninges, vascular cancer | Recruiting | Not applicable | 2024-10-15 | NCT04501705 | |
| Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent Gliomas | Disease Attributes, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 2 | 2024-10-15 | NCT04267978 | |
| Camrelizumab for Patients with Recurrent Primary Central Nervous System Lymphoma (PCNSL) | primary central nervous system lymphoma | Recruiting | Phase 2 | 2024-10-15 | NCT04070040 |